Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis
Abstract: Objective: To present a case with infliximab-induced retrobulbar optic neuritis.Case description: A 58-year-old woman presented to our clinic with a two-day history of blurred vision in her right eye. She had numerous uveitis attacks previously, and she was on infliximab treatment for ankylosing spondylitis. Her best-corrected visual acuity was counting fingers and 20/25 in the right and left eye, respectively. Optic discs seemed healthy in fundoscopic examination. The right optic nerve showed high signal intensity on magnetic resonance imaging (MRI). Infliximab treatment was discontinued and systemic steroid therapy was started. After the treatment her best-corrected visual acuity improved to 20/20 in her right eye.Conclusion: Infliximab is a chimeric human-murine monoclonal antibody used in autoimmune diseases. Optic neuritis is a rare but important side effect of infliximab. Thus, infliximab-induced optic neuritis should be kept in mind for patients receiving infliximab trea...
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis ; volume:13 ; day:12 ; month:12 ; year:2023
GMS ophthalmology cases ; 13 (12.12.2023)
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Dündar, Sema
Yasar, Mimbay
Çakmak, Harun
Kiylioglu, Nefati
Ünsal, Alparslan
- DOI
-
10.3205/oc000232
- URN
-
urn:nbn:de:0183-oc0002324
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dündar, Sema
- Yasar, Mimbay
- Çakmak, Harun
- Kiylioglu, Nefati
- Ünsal, Alparslan
Ähnliche Objekte (12)
Body mass index influences the response to infliximab in ankylosing spondylitis
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study
Andersson lesion in ankylosing spondylitis
Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study
T cell responses to putative antigens and downregulation of cytokineproduction by infliximab in ankylosing spondylitis patients
T-cell response to putative antigens and downregulation of cytokine production by infliximab in ankylosing spondylitis patients
T-cell responses to putative antigens and downregulation of cytokine production by infliximab in ankylosing spondylitis patients
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
MOG antibody-associated optic neuritis
Review of atypical optic neuritis
Body mass index influences the response to infliximab in ankylosing spondylitis
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study
Andersson lesion in ankylosing spondylitis
Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study
T cell responses to putative antigens and downregulation of cytokineproduction by infliximab in ankylosing spondylitis patients
T-cell response to putative antigens and downregulation of cytokine production by infliximab in ankylosing spondylitis patients
T-cell responses to putative antigens and downregulation of cytokine production by infliximab in ankylosing spondylitis patients
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
MOG antibody-associated optic neuritis
Review of atypical optic neuritis
Body mass index influences the response to infliximab in ankylosing spondylitis
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study
Andersson lesion in ankylosing spondylitis
Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study
T cell responses to putative antigens and downregulation of cytokineproduction by infliximab in ankylosing spondylitis patients
T-cell response to putative antigens and downregulation of cytokine production by infliximab in ankylosing spondylitis patients
T-cell responses to putative antigens and downregulation of cytokine production by infliximab in ankylosing spondylitis patients
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
MOG antibody-associated optic neuritis